Publications by authors named "Robert Holgate"

Claim this Profile
S
Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein.
Mario F Munoz Pinto, Sandra J Campbell, Christina Simoglou Karali, Vanessa A Johanssen, Claire Bristow, Robert Holgate

Neuro Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injury.
Anissa A Widjaja, Jinrui Dong, Eleonora Adami, Sivakumar Viswanathan, Benjamin Ng, Robert Holgate

Sci Transl Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A powered prosthetic ankle joint for walking and running.
Martin Grimmer, Matthew Holgate, Robert Holgate, Alexander Boehler, Jeffrey Ward

Biomed Eng Online· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A deimmunised form of the ribotoxin, α-sarcin, lacking CD4+ T cell epitopes and its use as an immunotoxin warhead.
Tim D Jones, Arron R Hearn, Robert G E Holgate, Dorota Kozub, Mark H Fogg

Protein Eng Des Sel· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The INNs and outs of antibody nonproprietary names.
Tim D Jones, Paul J Carter, Andreas Plückthun, Max Vásquez, Robert G E Holgate

MAbs· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity.
Robert G E Holgate, Richard Weldon, Timothy D Jones, Matthew P Baker

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A variant human IgG1-Fc mediates improved ADCC.
Ross Stewart, George Thom, Michaela Levens, Gülin Güler-Gane, Robert Holgate

Protein Eng Des Sel· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circumventing immunogenicity in the development of therapeutic antibodies.
Robert G E Holgate, Matthew P Baker

IDrugs· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis